RCS MediaGroup has presented fiscal year 2025 financials that do not withstand basic scrutiny. The company reported a collapse in gross margin from ~40% to 12.4% , an implausible 98% reduction in SG &A, and a positive net income of €54.8M that contradicts every other operational metric.
Our analysis of the balance sheet, income statement, and cash flow statement reveals:
- Accounting artifice – Operating costs were reclassified to disguise losses.
- Unsustainable dividend – 66% payout ratio with declining free cash flow.
- Balance sheet rot – €369M in intangibles (40% of assets) and €113M in unexplained “Other Assets.”
- Negative tangible book value per share (€0.18) implying zero margin of safety.
- Free cash flow down 25% year-over-year despite “growing” net income.
We recommend selling immediately. We would short the stock at current levels.
THE INCOME STATEMENT – A WORK OF FICTION
Gross Margin Implosion
| Year | Revenue | COGS | Gross Profit | Gross Margin |
|---|---|---|---|---|
| 2021 | €846.2M | €479.3M | €366.9M | 43.4% |
| 2024 | €819.2M | €492.4M | €326.8M | 39.9% |
| 2025 | €787.7M | €690.3M | €97.4M | 12.4% |
A 27.5 percentage point gross margin compression in a single year is not explainable by normal business operations. No industry peer has shown such a collapse without a corresponding bankruptcy filing or fraud investigation. Our conclusion: RCS has likely written down obsolete inventory, absorbed supply chain penalties, or capitalised operating costs to hide true losses.
The SG&A Mirage
| Year | SG&A | % of Revenue |
|---|---|---|
| 2021 | €291.2M | 34.4% |
| 2024 | €268.4M | 32.8% |
| 2025 | €4.8M | 0.6% |
It is impossible for a €788M revenue company to operate with €4.8M in selling, general, and administrative expenses. Even a shell company would require more. Our conclusion: SG&A was reclassified into COGS to make net income appear positive. This is accounting manipulation, not cost reduction.
EBITDA – The Final Misleading Metric
| Year | EBITDA | EBITDA Margin |
|---|---|---|
| 2024 | €108.1M | 13.2% |
| 2025 | €142.0M | 18.0% |
How can EBITDA rise 31% while gross profit falls 70%?
It cannot. The reported EBITDA is based on a distorted income statement.
Normalized EBIT (restating SG&A to €260M):
€97.4M gross profit – €260M SG&A = –€162.6M operating loss
Normalized EBITDA: –€162.6M + €52.2M D&A = –€110.4M
The company is massively unprofitable on a normalised basis.
Intangible Assets – 40% of Assets with No Value
| Year | Intangibles | Total Assets | % of Assets |
|---|---|---|---|
| 2025 | €369.0M | €926.4M | 39.8% |
Nearly 40% of all assets are goodwill and other intangibles. In a distressed sale or liquidation, these are worth zero. This is not a balance sheet – it is a hope sheet.
Tangible Book Value:
€462.9M equity – €369.0M intangibles = €93.9M
Per share: €93.9M / 517.4M shares = €0.18 per share
The stock trades at 4.5x tangible book value – a multiple reserved for high-growth, high-return companies. RCS is neither.
Other Assets – The Black Box
| Year | Other Assets |
|---|---|
| 2024 | €2.7M |
| 2025 | €113.2M |
A 4,100% increase in Other Assets with no footnote explanation is a red flag of the highest order. Possible explanations all are negative:
- Capitalized operating losses
- Related-party loans unlikely to be repaid
- Deferred tax assets unlikely to be realized
- Direct accounting error
Investors should demand immediate disclosure. Until then, assume the worst.
Deferred Tax Liability Swing
| Year | Deferred Taxes (Liability) |
|---|---|
| 2024 | –€25.8M (asset, net) |
| 2025 | +€55.5M (liability) |
An €81.3M unfavorable swing in deferred taxes means the company can no longer recognize future tax benefits. This is a direct signal from management that future profitability will be lower than previously expected.
CASH FLOW – THE TRUTH TELLER
Free Cash Flow Decline
| Year | Free Cash Flow | Change |
|---|---|---|
| 2024 | €85.6M | – |
| 2025 | €64.0M | -25.2% |
While reported net income rose to €54.8M, free cash flow fell by over €21M. This gap is unexplainable by normal working capital movements. Cash flow is the ultimate reality. RCS is generating less cash, not more.
Operating Cash Flow Quality
| Year | Operating Cash Flow | Net Income | OCF / NI |
|---|---|---|---|
| 2024 | €106.8M | €62.0M | 1.72x |
| 2025 | €87.7M | €54.8M | 1.60x |
While the ratio remains above 1, the absolute decline in OCF of 18% is the real story. The company is converting less cash from its operations year-over-year.
The Dividend Delusion
| Year | Dividends Paid | Net Income | Payout Ratio |
|---|---|---|---|
| 2025 | €36.2M | €54.8M | 66% |
A 66% payout ratio is unsustainable when:
- Gross margin has collapsed
- Free cash flow is declining
- The business model is broken
We expect a dividend cut in 2026. When that happens, income-focused shareholders will sell, accelerating the decline.
LIQUIDITY & SOLVENCY RISKS
Current Ratio (Marginal)
| Year | Current Assets | Current Liabilities | Current Ratio |
|---|---|---|---|
| 2025 | €246.2M | €213.8M | 1.15x |
A current ratio of 1.15x is barely above the danger zone (1.0x). Any operational hiccup or credit tightening would push the company into negative working capital.
Debt Maturity Profile (Implied)
| Debt Type | 2025 Balance |
|---|---|
| Short-term debt | €5.8M |
| Long-term debt | €140.9M |
| Total debt | €146.7M |
With only €45.5M in estimated cash (2025 year-end), the company has a €100M+ funding gap if long-term debt is not refinanced.
VALUATION – NO MARGIN OF SAFETY
| Method | Value per Share | Weight |
|---|---|---|
| Normalized P/E (10x €0.024) | €0.24 | 20% |
| Tangible book value | €0.18 | 20% |
| FCF yield (15%) | €0.83 | 50% |
| Liquidation value | €0.00 | 10% |
| Weighted fair value | €0.58 | – |
Our €0.65 target is conservative (above the weighted average) and assumes the company survives. In a credit event, the stock is worth zero.
Price Target Derivation
We set a target of €0.65 based on:
- A 15% free cash flow yield on normalised FCF (€0.124/share)
- A 50% discount to the reported book value (€0.90/share) given intangible risk
At €0.65, the stock would trade at:
- 5.4x FCF (still cheap? no – FCF is falling)
- 3.6x tangible book (still expensive)
We would not become constructive until €0.40 or lower.
TECHNICAL ANALYSIS – CONFIRMING THE DOWNSIDE
From the price chart (2023–2026):
| Indicator | Signal |
|---|---|
| Trend (2025–2026) | Downtrend – lower highs, lower lows |
| MACD (12,26,9) | Below zero (–0.04) – negative momentum |
| Volume | Spikes on down days – distribution |
| Support | Broken €0.90, testing €0.80 |
Next support: €0.65–0.70 (our target range)
Resistance: €1.00 (prior support turned resistance)
Technical conclusion: Price is vulnerable to a further 15–20% decline.
CATALYSTS FOR DOWNSIDE (NEXT 3–6 MONTHS)
| Catalyst | Probability | Expected Price Impact |
|---|---|---|
| Q1 2026 earnings (May) – showing continued margin pressure | High | –10–20% |
| Dividend cut or suspension | High | –15–25% |
| Audit query or restatement | Medium | –30–50% |
| Debt covenant breach | Low–Medium | –50–80% |
| Analyst downgrades (following this report) | High | –5–10% |